Dengue Fever

Infectious Disease·MeSH: Dengue

Prevalence

5.0 / 100K

4 drugs in development·3 companies·5 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
BinaxNOW® / Panbio® rapid testing platforms	ABBOTT LABORATORIES (ABT)

Phase 3(2)

Drug	Company
tdv	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tdv	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Unknown(1)

Drug	Company
BinaxNOW® and Panbio® rapid testing platforms	ABBOTT LABORATORIES (ABT)

BioSniper tracks 4 drugs in development for Dengue Fever across 3 companies.

There are 5 clinical trials targeting Dengue Fever tracked by BioSniper.

The estimated prevalence of Dengue Fever is approximately 5.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.